Načítá se...
Low-density lipoprotein cholesterol lowering treatment: the current approach
In the last 50 years, several clinical and epidemiological studies during have shown that increased levels of low-density lipoprotein cholesterol (LDLc) are associated with the development and progression of atherosclerotic lesions. The discovery of β-Hydroxy β-methylglutaryl-CoA reductase inhibitor...
Uloženo v:
| Vydáno v: | Lipids Health Dis |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201678/ https://ncbi.nlm.nih.gov/pubmed/32375792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-020-01275-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|